COMPASS Pathways(CMPS) - 2024 Q2 - Quarterly Results

Compass Pathways announces second quarter 2024 financial results and business highlights • Top-line COMP005 data for COMP360 phase 3 pivotal program in treatmentresistant depression expected in fourth quarter 2024 • Gino Santini to join Board of Directors as Chairman • Lori Englebert named new Chief Commercial Officer • Cash position of $228.6 million • Conference call August 1 at 8:00 am ET (1:00 pm UK) London and New York, August 1, 2024 Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a biotechnology com ...